Avidity Biosciences
RNA
#1842
Rank
A$16.27 B
Marketcap
A$108.01
Share price
-0.06%
Change (1 day)
113.45%
Change (1 year)

Market capitalization of Avidity Biosciences (RNA)

Market cap: A$16.27 Billion

As of December 2025 Avidity Biosciences has a market cap of A$16.27 Billion. This makes Avidity Biosciences the world's 1842th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avidity Biosciences from 2020 to 2025

End of year Market Cap

Year Marketcap Change
2025A$16.27 B181.78%
2024A$5.77 B449.14%
2023A$1.05 B-51.47%
2022A$2.16 B40.95%
2021A$1.53 B23.46%
2020A$1.24 B

End of Day market cap according to different sources

On Dec 22nd, 2025 the market cap of Avidity Biosciences was reported to be:

A$16.28 Billion
by Nasdaq info icon info icon
A$16.28 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
PTC Therapeutics
PTCT
A$9.33 B-42.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
A$1.22 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
A$3.43 B-78.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
A$4.43 B-72.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
A$0.16 B-98.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
A$16.36 B 0.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$212.98 B 1,208.73%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$147.79 B 808.14%๐Ÿ‡ฌ๐Ÿ‡ง UK